JP2007534728A5 - - Google Patents

Download PDF

Info

Publication number
JP2007534728A5
JP2007534728A5 JP2007510053A JP2007510053A JP2007534728A5 JP 2007534728 A5 JP2007534728 A5 JP 2007534728A5 JP 2007510053 A JP2007510053 A JP 2007510053A JP 2007510053 A JP2007510053 A JP 2007510053A JP 2007534728 A5 JP2007534728 A5 JP 2007534728A5
Authority
JP
Japan
Prior art keywords
extract
composition
antigen
allergen
allergenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007510053A
Other languages
English (en)
Japanese (ja)
Other versions
JP4932704B2 (ja
JP2007534728A (ja
Filing date
Publication date
Priority claimed from ES200401023A external-priority patent/ES2246695B1/es
Application filed filed Critical
Publication of JP2007534728A publication Critical patent/JP2007534728A/ja
Publication of JP2007534728A5 publication Critical patent/JP2007534728A5/ja
Application granted granted Critical
Publication of JP4932704B2 publication Critical patent/JP4932704B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007510053A 2004-04-29 2005-04-28 メチルビニルエーテル−無水マレイン酸コポリマーを基材とするナノ粒子を含んでなる免疫応答刺激組成物 Expired - Lifetime JP4932704B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200401023 2004-04-29
ES200401023A ES2246695B1 (es) 2004-04-29 2004-04-29 Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
PCT/ES2005/000225 WO2005105056A1 (es) 2004-04-29 2005-04-28 Composición estimuladora de la respuesta inmunitaria que comprende nanopartículas a base de un copolímero de metil vinil éter y anhídrido maleico

Publications (3)

Publication Number Publication Date
JP2007534728A JP2007534728A (ja) 2007-11-29
JP2007534728A5 true JP2007534728A5 (https=) 2008-06-19
JP4932704B2 JP4932704B2 (ja) 2012-05-16

Family

ID=35241413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007510053A Expired - Lifetime JP4932704B2 (ja) 2004-04-29 2005-04-28 メチルビニルエーテル−無水マレイン酸コポリマーを基材とするナノ粒子を含んでなる免疫応答刺激組成物

Country Status (12)

Country Link
US (1) US8895067B2 (https=)
EP (1) EP1752141B1 (https=)
JP (1) JP4932704B2 (https=)
CN (1) CN1976687B (https=)
AU (1) AU2005237269B2 (https=)
BR (1) BRPI0509828B1 (https=)
CA (1) CA2564974C (https=)
DE (1) DE602005015441D1 (https=)
ES (2) ES2246695B1 (https=)
MX (1) MXPA06012527A (https=)
RU (1) RU2379028C2 (https=)
WO (1) WO2005105056A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US7396886B2 (en) * 2005-06-21 2008-07-08 Isp Investments Inc. Process for making copolymers of maleic anhydride and alkyl vinyl ether of high specific viscosity
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
CA2648099C (en) 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
JP5630998B2 (ja) 2006-05-15 2014-11-26 マサチューセッツ インスティテュート オブ テクノロジー 機能的粒子のためのポリマー
ES2286951B1 (es) * 2006-05-26 2008-10-01 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas bioadhesivas para la administracion de moleculas biologicamente activas.
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
EP2134830A2 (en) 2007-02-09 2009-12-23 Massachusetts Institute of Technology Oscillating cell culture bioreactor
JP2010523595A (ja) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー ポリ（アミノ酸）ターゲッティング部分
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
JP2011500569A (ja) 2007-10-12 2011-01-06 マサチューセッツ インスティテュート オブ テクノロジー ワクチンナノテクノロジー
JP2010077057A (ja) * 2008-09-25 2010-04-08 Kagoshima Univ 抗食物アレルギーワクチン
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8277812B2 (en) * 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
WO2010114912A1 (en) * 2009-03-31 2010-10-07 University Of North Carolina At Greensboro Minimally invasive assessment of ige mediated allergy
BRPI1012036A2 (pt) 2009-05-27 2017-10-10 Selecta Biosciences Inc nanocarreadores que possuem componentes com diferentes taxas de liberação
CA2798739A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
EP2510930A1 (en) * 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof
ES2369949B1 (es) * 2011-05-19 2013-08-13 Universidade De Santiago De Compostela Microesferas poliméricas como adyuvantes en la producción de vacunas frente a parásitos escuticociliados de peces.
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
CN110064049B (zh) 2012-06-21 2024-02-09 西北大学 肽缀合粒子
KR102233251B1 (ko) 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
US11033493B2 (en) 2013-12-02 2021-06-15 Intelgenx Corp. Film dosage form with extended release mucoadhesive particles
US10272038B2 (en) 2013-12-02 2019-04-30 Intelgenx Corp. Film dosage form with extended release mucoadhesive particles
US9668970B2 (en) * 2013-12-02 2017-06-06 Intelgenx Corp. Film dosage form with extended release mucoadhesive particles
JP6706261B2 (ja) 2014-12-01 2020-06-03 インノウプ、ファルマ、ソシエダッド、リミターダＩｎｎｏｕｐ Ｆａｒｍａ， Ｓ．Ｌ． 化合物を封入するためのナノ粒子、その製造および使用
CN112057610A (zh) * 2019-06-10 2020-12-11 中国科学院宁波材料技术与工程研究所 一种超小纳米免疫增强剂-抗原复合纳米粒子及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
GB8601100D0 (en) 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
FR2634397B2 (fr) * 1986-12-31 1991-04-19 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
SE8900422D0 (sv) 1989-02-08 1989-02-08 Pharmacia Ab Tvaerbundna hyaluronatgeler samt foerfarande foer framstaellning av dessa
IT1247472B (it) 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
AU636544B1 (en) 1991-11-27 1993-04-29 Lignyte Co., Ltd. Water insoluble biocompatible hyaluronic acid polyion complex and method of making the same
US5565215A (en) 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US20010053359A1 (en) 1994-07-26 2001-12-20 Peter Watts Drug delivery composition for the nasal administration of antiviral agents
AU3159595A (en) 1994-08-30 1996-03-22 Hyal Pharmaceutical Corporation Hyaluronic acid and derivatives for modulation of cellular activity
ES2098188B1 (es) 1995-05-11 1997-12-16 Univ Santiago Compostela Desarrollo de nanoparticulas a base de polimeros hidrofilicos.
ES2098189B1 (es) 1995-05-23 1997-12-16 Fernandez Arenas Antonio Sistema para la toma de impresiones destinadas a la confeccion de protesis dentales implantosoportadas y medios para su realizacion.
EP0752245B1 (en) 1995-07-05 2002-05-22 European Community Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery
WO1997004747A1 (en) 1995-07-27 1997-02-13 Dunn James M Drug delivery systems for macromolecular drugs
US7276251B2 (en) 1997-04-01 2007-10-02 Lg Life Sciences, Ltd., Inc. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
ES2114502B1 (es) 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
WO1999018934A1 (en) 1997-10-09 1999-04-22 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
DE19810965A1 (de) 1998-03-13 1999-09-16 Aventis Res & Tech Gmbh & Co Nanopartikel, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2777193B1 (fr) 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
FR2777895A1 (fr) 1998-04-28 1999-10-29 Debio Rech Pharma Sa Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
US20030059465A1 (en) 1998-05-11 2003-03-27 Unger Evan C. Stabilized nanoparticle formulations of camptotheca derivatives
EP1107783B1 (en) 1998-09-01 2006-04-05 ELAN CORPORATION, Plc Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
IN191203B (https=) 1999-02-17 2003-10-04 Amarnath Prof Maitra
WO2000064954A1 (en) 1999-04-22 2000-11-02 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
EP1194128A2 (en) 1999-06-23 2002-04-10 Sedum Laboratories Ionically formulated biomolecule microcarriers
US20020009466A1 (en) 1999-08-31 2002-01-24 David J. Brayden Oral vaccine compositions
DK1223990T3 (da) 1999-10-15 2004-11-29 Inst Genetics Llc Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
US6743446B2 (en) 1999-12-15 2004-06-01 The Ohio State University Research Foundation Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US6465425B1 (en) 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
EP1187602A4 (en) 2000-04-18 2004-09-15 Peptron Inc SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME
WO2001082724A2 (en) 2000-05-03 2001-11-08 Natural As Compositions containing aminopolysaccharides and negatively charged polysaccharides
US6773695B2 (en) * 2000-10-05 2004-08-10 Mannkind Corporation Modulation of allergic response
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
ES2178961B1 (es) * 2001-03-06 2004-07-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Fabricacion de nanoparticulas a base del copolimero de metil vinil eter y anhidrido maleico para la administracion de farmacos de naturaleza hidrofilica, en particular de bases puricas y pirimidinicas.
WO2003049701A2 (en) * 2001-12-10 2003-06-19 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
ES2221530B1 (es) 2002-07-19 2006-02-16 Universidad De Santiago De Compostela Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.
US7273327B2 (en) 2003-06-20 2007-09-25 Colgate-Palmolive Company Oral care implement
BRPI0412835A (pt) 2003-08-12 2006-09-26 Octapharma Ag processo para preparação de uma solução de alfa-1-antitripsina
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.

Similar Documents

Publication Publication Date Title
JP2007534728A5 (https=)
RU2006142094A (ru) Композиция, стимулирующая иммунный ответ, содержащая наночастицы на основе сополимера метилвинилового эфира малеинового ангидрида
Hernandez-Pando et al. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance
Wu et al. Intranasal vaccination with mannosylated chitosan formulated DNA vaccine enables robust IgA and cellular response induction in the lungs of mice and improves protection against pulmonary mycobacterial challenge
CN105491982B (zh) 用于增强透皮递送的肽
JP5713672B2 (ja) 結核のワクチンおよびその使用方法
US20080014281A1 (en) Chitin Micro-Particles As An Adjuvant
WO2004089299A3 (en) Pulsatile transdermally administered antigens and adjuvants
JP2010523711A5 (https=)
JP2005526085A5 (https=)
JP2016539105A5 (https=)
Gholap et al. Importance of carbohydrate-drug conjugates in vaccine development: A detailed review
Chablani et al. Formulation and evaluation of a particulate oral breast cancer vaccine
Emikpe et al. Ex-vivo evaluation of the mucoadhesive properties of Cedrela odorata and Khaya senegalensis gums with possible applications for veterinary vaccine delivery
CN103157108B (zh) 免疫调节剂组合物及其药物组合物和应用
Suresh et al. Evaluation of mucosal adjuvants to chitosan-nanoparticle-based oral subunit vaccine for controlling salmonellosis in broilers
Hilleman et al. Polyvalent pneumococcal polysaccharide vaccines
KR101849831B1 (ko) M 세포 표적 펩타이드-항원 결합체 및 점막점착제를 포함하는 백신 조성물
CN105903034A (zh) 一种香菇多糖修饰的碳纳米管及其制备方法与应用
Keshavarz Valian et al. Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis
Bakir et al. Heat-killed Mycobacterium bovis-bacillus Calmette Guerin-suppressed total serum IgE response in ovalbumin-sensitized newborn mice
JP2011518760A5 (https=)
HRP20151356T1 (hr) Postupci za poboljšanje adjuvantnosti pripravaka za cjepiva
CN114272367B (zh) 一种口服狂犬病病毒样颗粒疫苗及其制备方法
Joshua et al. Abated immune responses against recombinant hepatitis-b vaccine by chitin in mice